Newsenselab GmbH, a Berlin, Germany-based provider of a migraines & headaches app, received seven-figure follow-up financing.
The round was led by Think.Health Ventures with participation from High-Tech Gründerfonds.
The company intends to use the funds to expand treatment offering and open the brand up to new markets.
Led by Stefan Greiner, CEO, Newsenselab provides M-sense, a certified medical app that allows users to follow a personalised and mobile migraine treatment plan, offers clinically validated treatment methods in the app and enables sufferers to proactively combat their headache pains, and can also learn from user data.
The product – available for Android and iOS devices – has around 80,000 users.